Primary Peritoneal Cavity Cancer [clinicaltrials_resource:d76bcbac2ba35a35ed6d4fab5681f856]
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers [clinicaltrials:NCT00002538]Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer [clinicaltrials:NCT00002600]Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00002717]Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer [clinicaltrials:NCT00002734]Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer [clinicaltrials:NCT00002894]Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00002895]SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) [clinicaltrials:NCT00002960]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00003064]clinicaltrials:NCT00003136Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum [clinicaltrials:NCT00003160]Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer [clinicaltrials:NCT00003322]Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00003345]Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00003358]Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer [clinicaltrials:NCT00003378]Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00003380]Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer [clinicaltrials:NCT00003382]Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00003385]Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum [clinicaltrials:NCT00003523]Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00003560]Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [clinicaltrials:NCT00003624]Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy [clinicaltrials:NCT00003634]Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00003636]Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00003670]Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer [clinicaltrials:NCT00003880]Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00003967]Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer [clinicaltrials:NCT00003998]Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00004012]Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer [clinicaltrials:NCT00004037]Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00004060]Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00004064]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors [clinicaltrials:NCT00004082]Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy [clinicaltrials:NCT00004115]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer [clinicaltrials:NCT00004221]Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00004934]Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer [clinicaltrials:NCT00005025]Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer [clinicaltrials:NCT00005026]Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer [clinicaltrials:NCT00005029]Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer [clinicaltrials:NCT00005046]ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment [clinicaltrials:NCT00005645]
condition [clinicaltrials_vocabulary:condition]
Primary Peritoneal Cavity Cancer [clinicaltrials_resource:d76bcbac2ba35a35ed6d4fab5681f856]
Bio2RDF identifier
d76bcbac2ba35a35ed6d4fab5681f856
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d76bcbac2ba35a35ed6d4fab5681f856
identifier
clinicaltrials_resource:d76bcbac2ba35a35ed6d4fab5681f856
title
Primary Peritoneal Cavity Cancer
@en
label
Primary Peritoneal Cavity Canc ...... bcbac2ba35a35ed6d4fab5681f856]
@en